ZyVersa Therapeutics, Inc.
ZVSA
$0.18
-$0.02-11.21%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.70M | -8.29M | -8.84M | -9.41M | -21.33M |
| Total Depreciation and Amortization | -7.80K | -6.10K | -3.50K | -900.00 | -106.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.52M | 785.70K | 768.10K | 924.80K | 12.71M |
| Change in Net Operating Assets | 1.25M | 2.38M | 2.55M | 960.10K | -361.70K |
| Cash from Operations | -5.93M | -5.13M | -5.52M | -7.53M | -9.09M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.09M | 3.87M | 3.87M | 6.54M | 8.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.24M | 1.22M | 1.23M | -618.30K | -863.90K |
| Cash from Financing | 6.33M | 5.09M | 5.10M | 5.92M | 7.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 405.10K | -47.40K | -422.10K | -1.61M | -1.46M |